Found 3 hits Enz. Inhib. hit(s) with Target = 'Orexin receptor type 2' and Ligand = 'BDBM386080' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Orexin receptor type 2
(Homo sapiens (Human)) | BDBM386080
![PNG](/data/jpeg/tenK38/BindingDB_386080.png) (N-((2R,3S)-1-acetyl-2-(((cis-4- (2,3,6- trifluorop...)Show SMILES CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1c(F)ccc(F)c1F |r,wU:19.23,16.16,13.14,7.7,(,-4.23,;1.33,-5,;1.33,-6.54,;2.67,-4.24,;4,-5.01,;5.33,-4.24,;5.33,-2.7,;4,-1.93,;4,-.39,;5.33,.38,;6.67,-.39,;4.56,1.72,;6.1,1.72,;2.67,-2.7,;1.33,-1.93,;1.33,-.39,;,.38,;-1.33,-.39,;-2.67,.38,;-2.67,1.92,;-1.33,2.69,;,1.92,;-4,2.69,;-5.33,1.92,;-5.33,.38,;-6.67,2.69,;-6.67,4.23,;-5.33,5,;-5.33,6.54,;-4,4.23,;-2.67,5,)| Show InChI InChI=1S/C21H29F3N2O4S/c1-13(27)26-11-3-4-18(25-31(2,28)29)19(26)12-30-15-7-5-14(6-8-15)20-16(22)9-10-17(23)21(20)24/h9-10,14-15,18-19,25H,3-8,11-12H2,1-2H3/t14-,15+,18-,19-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | n/a | n/a | 5.30 | n/a | n/a | n/a | n/a |
AstraZeneca
| Assay Description Chinese hamster ovary (CHO) dhfr-cells forcibly expressing human orexin type 2 receptor (hOX2R) were seeded in each well of Black clear bottom plate ... |
J Med Chem 50: 2213-24 (2007)
BindingDB Entry DOI: 10.7270/Q2Z321Z2 |
More data for this Ligand-Target Pair | |
Orexin receptor type 2
(Homo sapiens (Human)) | BDBM386080
![PNG](/data/jpeg/tenK38/BindingDB_386080.png) (N-((2R,3S)-1-acetyl-2-(((cis-4- (2,3,6- trifluorop...)Show SMILES CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1c(F)ccc(F)c1F |r,wU:19.23,16.16,13.14,7.7,(,-4.23,;1.33,-5,;1.33,-6.54,;2.67,-4.24,;4,-5.01,;5.33,-4.24,;5.33,-2.7,;4,-1.93,;4,-.39,;5.33,.38,;6.67,-.39,;4.56,1.72,;6.1,1.72,;2.67,-2.7,;1.33,-1.93,;1.33,-.39,;,.38,;-1.33,-.39,;-2.67,.38,;-2.67,1.92,;-1.33,2.69,;,1.92,;-4,2.69,;-5.33,1.92,;-5.33,.38,;-6.67,2.69,;-6.67,4.23,;-5.33,5,;-5.33,6.54,;-4,4.23,;-2.67,5,)| Show InChI InChI=1S/C21H29F3N2O4S/c1-13(27)26-11-3-4-18(25-31(2,28)29)19(26)12-30-15-7-5-14(6-8-15)20-16(22)9-10-17(23)21(20)24/h9-10,14-15,18-19,25H,3-8,11-12H2,1-2H3/t14-,15+,18-,19-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | n/a | n/a | 5.30 | n/a | n/a | n/a | n/a |
TBA
| Assay Description Chinese hamster ovary (CHO) dhfr-cells forcibly expressing human orexin type 2 receptor (hOX2R) were seeded in each well of Black clear bottom plate ... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2CZ3BCW |
More data for this Ligand-Target Pair | |
Orexin receptor type 2
(Homo sapiens (Human)) | BDBM386080
![PNG](/data/jpeg/tenK38/BindingDB_386080.png) (N-((2R,3S)-1-acetyl-2-(((cis-4- (2,3,6- trifluorop...)Show SMILES CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1c(F)ccc(F)c1F |r,wU:19.23,16.16,13.14,7.7,(,-4.23,;1.33,-5,;1.33,-6.54,;2.67,-4.24,;4,-5.01,;5.33,-4.24,;5.33,-2.7,;4,-1.93,;4,-.39,;5.33,.38,;6.67,-.39,;4.56,1.72,;6.1,1.72,;2.67,-2.7,;1.33,-1.93,;1.33,-.39,;,.38,;-1.33,-.39,;-2.67,.38,;-2.67,1.92,;-1.33,2.69,;,1.92,;-4,2.69,;-5.33,1.92,;-5.33,.38,;-6.67,2.69,;-6.67,4.23,;-5.33,5,;-5.33,6.54,;-4,4.23,;-2.67,5,)| Show InChI InChI=1S/C21H29F3N2O4S/c1-13(27)26-11-3-4-18(25-31(2,28)29)19(26)12-30-15-7-5-14(6-8-15)20-16(22)9-10-17(23)21(20)24/h9-10,14-15,18-19,25H,3-8,11-12H2,1-2H3/t14-,15+,18-,19-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | n/a | n/a | 5.30 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description Chinese hamster ovary (CHO) dhfr-cells forcibly expressing human orexin type 2 receptor (hOX2R) were seeded in each well of Black clear bottom plate ... |
US Patent US10508083 (2019)
BindingDB Entry DOI: 10.7270/Q29S1TD1 |
More data for this Ligand-Target Pair | |